Chemotherapy-induced peripheral neuropathy is caused by cancer treatment, but doctors don’t have a way to treat it. Our research is changing that.
We’re helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people.
Researchers at the University of Sheffield have developed a new magnetic device we could use to make more chemotherapy drugs effective against brain tumours.
Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to a trial we funded.
A new study has found that the level of a person’s immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.
Find out how the chemistry inside plants can lead to life-changing drugs and how a cannabis-derived drug is part of a new trial to help people with a type of aggressive brain cancer.
Following its approval in Scotland 2 weeks ago, a new treatment will now be available on the NHS in England for some people with prostate cancer.
The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.
The National Institute for Health and Care Excellence has recommended a new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma.
New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma.